Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ARIPIPRAZOLE Cause Maternal exposure timing unspecified? 22 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Maternal exposure timing unspecified have been filed in association with ARIPIPRAZOLE (Aripiprazole). This represents 0.0% of all adverse event reports for ARIPIPRAZOLE.

22
Reports of Maternal exposure timing unspecified with ARIPIPRAZOLE
0.0%
of all ARIPIPRAZOLE reports
0
Deaths
6
Hospitalizations

How Dangerous Is Maternal exposure timing unspecified From ARIPIPRAZOLE?

Of the 22 reports, 6 (27.3%) required hospitalization.

Is Maternal exposure timing unspecified Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ARIPIPRAZOLE. However, 22 reports have been filed with the FAERS database.

What Other Side Effects Does ARIPIPRAZOLE Cause?

Drug ineffective (5,566) Off label use (5,473) Product use in unapproved indication (4,792) Weight increased (4,636) Anxiety (3,076) Suicide attempt (2,796) Suicidal ideation (2,618) Condition aggravated (2,157) Insomnia (2,147) Akathisia (2,107)

What Other Drugs Cause Maternal exposure timing unspecified?

RITUXIMAB (402) METHOTREXATE (350) ADALIMUMAB (343) DICLOFENAC (331) TOCILIZUMAB (327) HYDROXYCHLOROQUINE (309) FOLIC ACID (304) INFLIXIMAB (303) LEFLUNOMIDE (302) SECUKINUMAB (301)

Which ARIPIPRAZOLE Alternatives Have Lower Maternal exposure timing unspecified Risk?

ARIPIPRAZOLE vs ARIPIPRAZOLE LAUROXIL ARIPIPRAZOLE vs ARIXTRA ARIPIPRAZOLE vs ARMODAFINIL ARIPIPRAZOLE vs AROMASIN ARIPIPRAZOLE vs ARSENIC TRIOXIDE

Related Pages

ARIPIPRAZOLE Full Profile All Maternal exposure timing unspecified Reports All Drugs Causing Maternal exposure timing unspecified ARIPIPRAZOLE Demographics